AAAAAA

   
Results: 1-8 |
Results: 8
Impact of the media and the Internet on oncology: Survey of cancer patients and oncologists in Canada
Authors: Chen, XY Siu, LL
Citation: Xy. Chen et Ll. Siu, Impact of the media and the Internet on oncology: Survey of cancer patients and oncologists in Canada, J CL ONCOL, 19(23), 2001, pp. 4291-4297
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies
Authors: Hidalgo, M Siu, LL Nemunaitis, J Rizzo, J Hammond, LA Takimoto, C Eckhardt, SG Tolcher, A Britten, CD Denis, L Ferrante, K Von Hoff, DD Silberman, S Rowinsky, EK
Citation: M. Hidalgo et al., Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies, J CL ONCOL, 19(13), 2001, pp. 3267-3279
Problems in interpreting clinical trials
Authors: Siu, LL Tannock, IF
Citation: Ll. Siu et If. Tannock, Problems in interpreting clinical trials, HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY, 2001, pp. 473-490
Oral paclitaxel and concurrent cyclosporin A: Targeting clinically relevant systemic exposure to paclitaxel
Authors: Britten, CD Baker, SD Denis, LJ Johnson, T Drengler, R Siu, LL Duchin, K Kuhn, J Rowinsky, EK
Citation: Cd. Britten et al., Oral paclitaxel and concurrent cyclosporin A: Targeting clinically relevant systemic exposure to paclitaxel, CLIN CANC R, 6(9), 2000, pp. 3459-3468
The Ali/Al-Sarraf article reviewed
Authors: Siu, LL Tannock, IF
Citation: Ll. Siu et If. Tannock, The Ali/Al-Sarraf article reviewed, ONCOLOGY-NY, 14(8), 2000, pp. 1237
Telomerase: Therapeutic potential in cancer
Authors: Davis, AJ Siu, LL
Citation: Aj. Davis et Ll. Siu, Telomerase: Therapeutic potential in cancer, CANCER INV, 18(3), 2000, pp. 269-277
Phase I and pharmacokinetic study of the differentiating agent vesnarinonein combination with gemcitabine in patients with advanced cancer
Authors: Patnaik, A Rowinsky, EK Tammara, BK Hidalgo, M Drengler, RL Garner, AM Siu, LL Hammond, LA Felton, SA Mallikaarjun, S Von Hoff, DD Eckhardt, SG
Citation: A. Patnaik et al., Phase I and pharmacokinetic study of the differentiating agent vesnarinonein combination with gemcitabine in patients with advanced cancer, J CL ONCOL, 18(23), 2000, pp. 3974-3985
Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors
Authors: Patnaik, A Warner, E Michael, M Egorin, MJ Moore, MJ Siu, LL Fracasso, PM Rivkin, S Kerr, I Litchman, M Oza, AM
Citation: A. Patnaik et al., Phase I dose-finding and pharmacokinetic study of paclitaxel and carboplatin with oral valspodar in patients with advanced solid tumors, J CL ONCOL, 18(21), 2000, pp. 3677-3689
Risultati: 1-8 |